Compound 266
Identifiers
- Canonical SMILES:
COC(=O)c1cccc(c1)S(=O)(=O)N1[C@@H]([C@H](c2ccc(Cl)cc2)n2c1ccc(C(=O)N1CCN(CC(=O)N3CCOCC3)CC1)c2=O)c1ccc(Cl)cc1
- IUPAC name:
methyl 3-[[(2R,3S)-2,3-bis(4-chlorophenyl)-6-[4-(2-morpholin-4-yl-2-oxoethyl)piperazine-1-carbonyl]-5-oxo-2,3-dihydroimidazo[1,2-a]pyridin-1-yl]sulfonyl]benzoate
- InChi:
InChI=1S/C38H37Cl2N5O8S/c1-52-38(49)27-3-2-4-30(23-27)54(50,51)45-32-14-13-31(36(47)43-17-15-41(16-18-43)24-33(46)42-19-21-53-22-20-42)37(48)44(32)34(25-5-9-28(39)10-6-25)35(45)26-7-11-29(40)12-8-26/h2-14,23,34-35H,15-22,24H2,1H3/t34-,35+/m0/s1
- InChiKey:
UPSHSSACCRDPOP-OIDHKYIRSA-N
External links
25052265 |
External search
Bibliography (1)
Publication | Name |
---|---|
Dominique Romyr, Robert Alan Goodnow, Qi Qiao, Binh Thanh Vu, F. Hoffmann-La Roche Ag. . Diphenyl-dihydro-imidazopyridinones None. | 62 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.33 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 793.17 g/mol | |||
HBA | 13 | |||
HBD | 0 | |||
HBA + HBD | 13 | |||
AlogP | 3.97 | |||
TPSA | 137.08 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2008125487 | 62 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 6.33 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4708 | Elismetrep | DB15287 | |
0.4222 | Omidenepag isopropyl | DB15071 | |
0.4221 | Relcovaptan | DB13929 | |
0.4206 | BMS-214662 | DB12234 | |
0.4205 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.4200 | VX-659 | DB15177 | |
0.4164 | Venetoclax | DB11581 | |
0.4160 | Nelivaptan | DB12643 | |
0.4147 | Ubrogepant | DB15328 | |
0.4101 | Elexacaftor | DB15444 | |
0.4092 | Alatrofloxacin | DB09335 | |
0.4079 | SC-74020 | DB01630 | |
0.4072 | Epelsiban | DB11934 | |
0.4067 | Navitoclax | DB12340 | |
0.4047 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 |